The abstract is read at the publisher; the summary is JClub's.
IL4I1 is significantly upregulated in keloid tissues, with activated tryptophan–kynurenine metabolism and increased lipid peroxidation products linked to fibrotic progression.
- Why it matters: Keloids remain refractory despite focus on TGF-β and fibroblasts, leaving a gap in immunometabolic mechanisms that sustain chronic inflammation and dysregulated fibrosis.
- What they did: The study tested Il4i1 loss in a skin fibrosis model and screened for inhibitors, identifying L-carnosine that blocks IL4I1 enzymatic activity and protein stability.
- The result: Il4i1 knockout suppressed collagen deposition, and L-carnosine showed prominent therapeutic efficacy in a keloid nude-mouse xenograft model, supporting IL4I1 as a druggable target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.